MARKET

AIKI

AIKI

AIkido Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.7779
+0.0219
+2.90%
Closed 19:57 09/17 EDT
OPEN
0.7400
PREV CLOSE
0.7560
HIGH
0.7870
LOW
0.7400
VOLUME
1.52M
TURNOVER
--
52 WEEK HIGH
2.550
52 WEEK LOW
0.4656
MARKET CAP
69.76M
P/E (TTM)
-6.0209
1D
5D
1M
3M
1Y
5Y
AIkido Pharma Releases Shareholder Update (Full Statement In Body)
Dear Shareholder, September is an opportune time to provide a shareholder and investor update and we are pleased to report on positive developments and near-term upcoming potential value creating catalysts. To start,
Benzinga · 5d ago
AIkido Pharma Offers Update On Use Of Machine Learning In Drug Development Program: 'The goal for the project is the identification and optimization of anti-viral compounds that inhibit viral replication by targeting a protein complex that degrades RNA...
AIkido Pharma Inc. (NASDAQ:AIKI) ("AIkido" or the "Company") today provided and update on the use of Machine Learning in support of its antiviral platform with the University of Maryland Baltimore
Benzinga · 08/06 14:02
AIkido Provides Update on Use of Machine Learning in Drug Development Program
/PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided and update on the use of Machine Learning in support of its antiviral platform with the School of Medicine.  The Company stated: 
PR Newswire - PRF · 08/06 14:00
Notice of Allowance Issued for Central Nervous System Peptide Technology
/PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for application No.: 16/477,125.  This technology relates to the use of novel and propr...
PR Newswire - PRF · 07/27 14:00
5 Value Stocks In The Healthcare Sector
What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most lik...
Benzinga · 07/26 14:24
AIkido Pharma issues update on antiviral platform with University of Maryland
AIkido Pharma ([[AIKI]] -0.8%) provided an update to the progress of its antiviral platform with the University of Maryland School of Medicine.As part of the project, scientists have identified 4
Seekingalpha · 07/16 14:23
AIkido Pharma Issues Update On Antiviral Platform With The University Of Maryland
AIkido Pharma Inc. (NASDAQ:AIKI) ("AIkido" or the "Company") today provided an update to the progress of its antiviral platform with the University of Maryland School of Medicine.  The
Benzinga · 07/16 14:01
AIkido Pharma Issues Update on Antiviral Platform with the University of Maryland
/PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided an update to the progress of its antiviral platform with the School of Medicine.  The Company stated:
PR Newswire - PRF · 07/16 14:00
More
Forecast
No Data
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of AIKI. Analyze the recent business situations of AIkido Pharma through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+0.49%
Pharmaceuticals & Medical Research
-0.10%
Key Executives
Non-Executive Chairman/Independent Director
Robert Vander Zanden
Chief Executive Officer/Chief Financial Officer/Chief Accounting Officer/Director
Anthony Hayes
Director
Robert Dudley
Director
Paul LeMire
Director
Kyle Wool
Independent Director
Gregory Blattner
Independent Director
Tim Ledwick
No Data
  • All
  • Financials
  • Insiders
More
About AIKI
Aikido Pharma Inc. is a biotechnology company. The Company is focused on developing a diverse portfolio of small-molecule anti-cancer therapeutics. Its diverse pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). In addition, the Company is constantly seeking to grow its pipeline to treat its unmet medical needs in oncology.

Webull offers kinds of Aikido Pharma Inc stock information, including NASDAQ:AIKI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AIKI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AIKI stock methods without spending real money on the virtual paper trading platform.